这是一篇来自已证抗体库的有关人类 TRAIL的综述,是根据16篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合TRAIL 抗体。
TRAIL 同义词: APO2L; Apo-2L; CD253; TL2; TNLG6A; TRAIL

BioLegend
小鼠 单克隆(RIK-2)
  • 免疫细胞化学; 人类; 1:50; 图 4d
BioLegend TRAIL抗体(BioLegend, RIK2)被用于被用于免疫细胞化学在人类样本上浓度为1:50 (图 4d). Nat Commun (2017) ncbi
小鼠 单克隆(RIK-2)
  • 流式细胞仪; 人类; 图 4c
BioLegend TRAIL抗体(Biolegend, 308210)被用于被用于流式细胞仪在人类样本上 (图 4c). Cell (2016) ncbi
小鼠 单克隆(RIK-2)
  • 抑制或激活实验; 人类; 图 4
BioLegend TRAIL抗体(biolegend, RIK-2)被用于被用于抑制或激活实验在人类样本上 (图 4). Leuk Res (2015) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4l
艾博抗(上海)贸易有限公司 TRAIL抗体(Abcam, ab9959)被用于被用于免疫印迹在人类样本上 (图 4l). Sci Adv (2021) ncbi
安迪生物R&D
小鼠 单克隆(75402)
  • 免疫组化-石蜡切片; 人类
安迪生物R&D TRAIL抗体(R&D Systems, MAB687)被用于被用于免疫组化-石蜡切片在人类样本上. Clin Breast Cancer (2015) ncbi
赛默飞世尔
小鼠 单克隆(RIK-2)
  • 流式细胞仪; 人类
赛默飞世尔 TRAIL抗体(eBioscience, RIK-2)被用于被用于流式细胞仪在人类样本上. Eur J Immunol (2015) ncbi
Novus Biologicals
小鼠 单克隆(55B709.3)
  • 免疫印迹; 人类; 1:1000; 图 10b
Novus Biologicals TRAIL抗体(Novus Bio, 55B709.3)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 10b). Mol Cell Biol (2017) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(C92B9)
  • 免疫印迹; 人类; 图 1j
赛信通(上海)生物试剂有限公司 TRAIL抗体(Cell Signaling Technology, C92B9)被用于被用于免疫印迹在人类样本上 (图 1j). elife (2021) ncbi
domestic rabbit 单克隆(C92B9)
  • 免疫印迹; 人类; 1:1000; 图 5b
赛信通(上海)生物试剂有限公司 TRAIL抗体(Cell Signaling Technology, 3219)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5b). Front Neurosci (2019) ncbi
domestic rabbit 单克隆(C92B9)
  • 免疫沉淀; 人类; 图 1e
赛信通(上海)生物试剂有限公司 TRAIL抗体(Cell Signaling, C92B9)被用于被用于免疫沉淀在人类样本上 (图 1e). Oncogene (2017) ncbi
domestic rabbit 单克隆(C92B9)
  • 流式细胞仪; 人类; 图 4c
赛信通(上海)生物试剂有限公司 TRAIL抗体(Cell Signaling, 3219S)被用于被用于流式细胞仪在人类样本上 (图 4c). Invest New Drugs (2015) ncbi
碧迪BD
小鼠 单克隆(RIK-2)
  • 流式细胞仪; 人类; 图 2b
碧迪BD TRAIL抗体(BD Biosciences, RIK-2)被用于被用于流式细胞仪在人类样本上 (图 2b). Sci Rep (2017) ncbi
小鼠 单克隆(RIK-2)
  • 流式细胞仪; 人类; 图 st1
碧迪BD TRAIL抗体(BD, 550516)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(RIK-2)
  • 流式细胞仪; 人类; 图 7
碧迪BD TRAIL抗体(BD Biosciences, 550516)被用于被用于流式细胞仪在人类样本上 (图 7). Retrovirology (2015) ncbi
小鼠 单克隆(B35-1)
  • 免疫印迹; 人类
碧迪BD TRAIL抗体(BD Biosciences, 556468)被用于被用于免疫印迹在人类样本上. Carcinogenesis (2009) ncbi
Developmental Studies Hybridoma Bank
小鼠 单克隆(AFFN-TNFSF10-11F2)
  • 免疫印迹; 人类; 1:1000; 图 3b
Developmental Studies Hybridoma Bank TRAIL抗体(DSHB, AFFN-TNFSF10-11F2)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3b). J Clin Med (2020) ncbi
文章列表
  1. Jeong D, Kim H, Kim H, Kang M, Jung H, Oh Y, et al. Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2. elife. 2021;10: pubmed 出版商
  2. Kitamura Y, Kanaya N, Moleirinho S, Du W, Reinshagen C, Attia N, et al. Anti-EGFR VHH-armed death receptor ligand-engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers. Sci Adv. 2021;7: pubmed 出版商
  3. Viana G, Priestman D, Platt F, Khan S, Tomatsu S, Pshezhetsky A. Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms. J Clin Med. 2020;9: pubmed 出版商
  4. Dong H, Ye X, Zhong L, Xu J, Qiu J, Wang J, et al. Role of FOXO3 Activated by HIV-1 Tat in HIV-Associated Neurocognitive Disorder Neuronal Apoptosis. Front Neurosci. 2019;13:44 pubmed 出版商
  5. Allan D, Cerdeira A, Ranjan A, Kirkham C, Aguilar O, Tanaka M, et al. Transcriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells. Sci Rep. 2017;7:3501 pubmed 出版商
  6. Iurlaro R, Püschel F, León Annicchiarico C, O Connor H, Martin S, Palou Gramón D, et al. Glucose Deprivation Induces ATF4-Mediated Apoptosis through TRAIL Death Receptors. Mol Cell Biol. 2017;37: pubmed 出版商
  7. Smith N, Pietrancosta N, Davidson S, Dutrieux J, Chauveau L, Cutolo P, et al. Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement. Nat Commun. 2017;8:14253 pubmed 出版商
  8. Roybal K, Williams J, Morsut L, Rupp L, Kolinko I, Choe J, et al. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell. 2016;167:419-432.e16 pubmed 出版商
  9. Li Z, Bridges B, Olson J, Weinman S. The interaction between acetylation and serine-574 phosphorylation regulates the apoptotic function of FOXO3. Oncogene. 2017;36:1887-1898 pubmed 出版商
  10. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  11. Heigele A, Joas S, Regensburger K, Kirchhoff F. Increased susceptibility of CD4+ T cells from elderly individuals to HIV-1 infection and apoptosis is associated with reduced CD4 and enhanced CXCR4 and FAS surface expression levels. Retrovirology. 2015;12:86 pubmed 出版商
  12. Difranco K, Johnson Farley N, Bertino J, Elson D, Vega B, Belinka B, et al. LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes. Leuk Res. 2015;39:649-56 pubmed 出版商
  13. Guzmán E, Maers K, Roberts J, Kemami Wangun H, Harmody D, Wright A. The marine natural product microsclerodermin A is a novel inhibitor of the nuclear factor kappa B and induces apoptosis in pancreatic cancer cells. Invest New Drugs. 2015;33:86-94 pubmed 出版商
  14. Ziblat A, Domaica C, Spallanzani R, Iraolagoitia X, Rossi L, Avila D, et al. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur J Immunol. 2015;45:192-202 pubmed 出版商
  15. Labovsky V, Martinez L, Davies K, Garcia Rivello H, Calcagno M, Matas A, et al. Association between ligands and receptors related to the progression of early breast cancer in tumor epithelial and stromal cells. Clin Breast Cancer. 2015;15:e13-21 pubmed 出版商
  16. Luce A, Courtin A, Levalois C, Altmeyer Morel S, Romeo P, Chevillard S, et al. Death receptor pathways mediate targeted and non-targeted effects of ionizing radiations in breast cancer cells. Carcinogenesis. 2009;30:432-9 pubmed 出版商